Bedaquiline: Difference between revisions
From IDWiki
(Created page with "* Antituberculosis antibiotic used as second-line therapy * Inhibits the ATP synthase proton pump in mycobacteria * Member of the diarylquinoline class of antibiotics Categ...") |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
* Inhibits the ATP synthase proton pump in mycobacteria |
* Inhibits the ATP synthase proton pump in mycobacteria |
||
* Member of the diarylquinoline class of antibiotics |
* Member of the diarylquinoline class of antibiotics |
||
* Adverse events include [[Adverse drug reaction::QTc prolongation]], [[Adverse drug reaction::hepatitis]], and possibly an increased risk of death |
|||
** Others: [[Adverse drug reaction::arthralgias]], [[Adverse drug reaction::dizziness]], [[Adverse drug reaction::headache]], [[Adverse drug reaction::hyperuremia]], [[Adverse drug reaction::insomnia]], [[Adverse drug reaction::myalgia]], [[Adverse drug reaction::nausea]], [[Adverse drug reaction::prolonged QTc]], [[Adverse drug reaction::pruritus]], and [[Adverse drug reaction::vomiting]] |
|||
[[Category:Antibiotics]] |
[[Category:Antibiotics]] |
||
Latest revision as of 03:20, 18 February 2020
- Antituberculosis antibiotic used as second-line therapy
- Inhibits the ATP synthase proton pump in mycobacteria
- Member of the diarylquinoline class of antibiotics
- Adverse events include QTc prolongation, hepatitis, and possibly an increased risk of death
- Others: arthralgias, dizziness, headache, hyperuremia, insomnia, myalgia, nausea, prolonged QTc, pruritus, and vomiting
